Medicare reminds providers that cervical cancer screening with high-risk HPV testing is covered as a preventive service for asymptomatic female patients ages 30–65 once every five years. To ensure proper reimbursement, laboratories and providers should bill HCPCS code G0476 when performing a covered high-risk HPV test in conjunction with a Pap test.
Practices should review their current billing and coding processes to confirm the correct code is being used for eligible Medicare patients. CMS has also provided educational resources outlining coverage requirements, billing guidance, and the applicable National Coverage Determination.
Additionally, CMS has announced the October 2026 update to the Laboratory National Coverage Determination (NCD) Edit Software. Laboratories should review the update and related documentation to stay current with Medicare billing edits and coverage requirements.
Resource: Cervical Cancer Screening with HPV Test
Screening Pap Tests & Pelvic Exams (PDF)
National Coverage Determination 210.2.1
Laboratory National Coverage Determination Edit Software: October 2026 Update